Current guidelines recommend 6 months of DAPT for stable coronary disease and 12 months for ACS post-PCI to prevent stent thrombosis and ischemic events.
Dual antiplatelet therapy (DAPT), combining aspirin with P2Y12 inhibitors such as clopidogrel or ticagrelor, forms the cornerstone of post-percutaneous coronary intervention (PCI) care aimed at preventing stent thrombosis and lowering the risk of ischemic events. Current medical guidelines recommend a 6-month duration of DAPT for stable coronary disease and 12 months for acute coronary syndrome (ACS).
No takes yet. Share an insight, caveat, or question.
Mehta et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: